Clinical characteristics, treatment patterns, and persistence in individuals with type 2 diabetes initiating a glucagon-like peptide-1 receptor agonist: a retrospective analysis of the diabetes prospective follow-up registry
Los receptores de GLP-1 (GLP-1R) se expresan en varios tejidos: clulas alfa y beta de los islotes pancreticos, SNC, corazn, rin, tracto gastrointestinal y pulmn
Sin embargo, su efecto en la secrecin de hormonas intestinales posprandiales como el GLP-1 no estaba claro
While these medications can be highly effective for weight management and metabolic health, their long-term affordability, sustainability and appropriate utilization remain key concerns. Cost and other GLP-1 coverage concerns As Hall references, employer healthcare costs already are soaring: Late last year, Mercer estimated that employers would see a 5.8% hike in healthcare costs in 2025, the third consecutive year of record-high increases
published online: 19 January 2017